secured or unsecured financings from banks or other lenders, proceeds from the sale of assets, and undistributed funds from operations.
We believe that our cash on-hand, anticipated net offering proceeds, and anticipated financing activities will be sufficient to meet our liquidity needs for the foreseeable future over the next 12 months and beyond.
Cash Flows. The following table summarizes our cash flows, as determined on a GAAP basis, for the following periods:
| | | | | | | | | |
| | For the Nine Months Ended September 30, | | | |
(in thousands) | | 2023 | | 2022 | | Change |
Total cash provided by (used in): | | | | | | | | | |
Operating activities | | $ | (8,705) | | $ | 80,451 | | $ | (89,156) |
Investing activities | | | (395,603) | | | (1,862,162) | | | 1,466,559 |
Financing activities | | | 341,267 | | | 1,646,374 | | | (1,305,107) |
Net (decrease) increase in cash, cash equivalents and restricted cash | | $ | (63,041) | | $ | (135,337) | | $ | 72,296 |
Cash flows from operating activities during the nine months ended September 30, 2023 decreased by approximately $89.2 million as compared to the same period in 2022, primarily as a result of (i) the partial cash settlement of the 2022 performance participation allocation owed in the amount of $77.8 million, while the 2021 performance participation allocation was settled entirely through the issuance of OP Units; (ii) a $48.0 million increase in interest expense related to our consolidated indebtedness as a result of increased borrowings and the effect of increased interest rates on certain variable rate debt, partially offset by the increase in our NOI, as described above.
Cash used in investing activities during the nine months ended September 30, 2023 decreased by approximately $1.5 billion as compared to the same period in 2022, primarily due to (i) a net decrease in acquisition activity of $1.6 billion, which was primarily driven by the closing of the BTC II Partnership Transaction and the acquisition of 40 additional industrial properties during the nine months ended September 30, 2022, as compared to the acquisition of four industrial properties during the nine months ended September 30, 2023; and (ii) a decrease in the contributions made to our joint venture partnerships of $8.0 million, partially offset by (i) a net increase in capital expenditure activity of $53.1 million related to increased development activity during the nine months ended September 30, 2023; and (ii) $103.5 million of investments in debt-related investments during the nine months ended September 30, 2023.
Cash provided by financing activities during the nine months ended September 30, 2023 decreased by approximately $1.3 billion as compared to the same period in 2022, primarily driven by (i) the $632.1 million decrease in capital raised through our public offering, net of offering costs paid; (ii) the $404.0 million increase in redemptions of our common stock; (iii) a decrease in net proceeds from financing obligations associated with the DST Program of $294.2 million; and (iv) a decrease in net borrowings of $45.5 million; partially offset by (i) $44.0 million of borrowings under the Morgan Stanley MRA (net of repayments), which closed during 2023; and (ii) a decrease related to $40.9 million Class I OP Units that were redeemed in the first quarter of 2022, while no OP Units were redeemed in the nine months ended September 30, 2023.
Capital Resources and Uses of Liquidity
In addition to our cash and cash equivalents balance available, our capital resources and uses of liquidity are as follows:
Line of Credit and Term Loans. As of September 30, 2023, we had an aggregate $2.2 billion of commitments under our credit agreements, including $1.0 billion under our line of credit and $1.2 billion under our two term loans. As of that date, we had $440.0 million outstanding under our line of credit with an effective interest rate of 6.03%, which includes the effect of two interest rate cap agreements. Additionally, as of September 30, 2023, we had $1.2 billion outstanding under our term loans with an effective interest rate of 3.16%, which includes the effect of the interest rate swap agreements and an interest rate cap agreement. The unused and available portions under our line of credit were both $560.0 million as of September 30, 2023. Our $1.0 billion line of credit matures in March 2025 and may be extended pursuant to two one-year extension options, subject to continuing compliance with certain financial covenants and other customary conditions. Our $550.0 million term loan matures in March 2027 and our $600.0 million term loan matures in May 2026. Our line of credit and term loan borrowings are available for general corporate purposes including, but not limited to, the acquisition and operation of permitted investments by us. Refer to “Note 6 to the Condensed Consolidated Financial Statements” for additional information regarding our line of credit and term loans.
Mortgage Notes. As of September 30, 2023, we had property-level borrowings of approximately $1.7 billion of principal outstanding with a weighted-average remaining term of 2.8 years. These borrowings are secured by mortgages or deeds of trust and related assignments and security interests in the collateralized properties, and had a weighted-average interest rate of 3.91%. Refer to “Note 6 to the Condensed Consolidated Financial Statements” for additional information regarding the mortgage notes.
Debt Covenants. Our line of credit, term loan and mortgage note agreements contain various property-level covenants, including customary affirmative and negative covenants. In addition, the agreements governing our line of credit and term loans contain certain corporate level financial covenants, including leverage ratio, fixed charge coverage ratio, and tangible net worth thresholds. These